Journal Watch 31/05/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
top of page
Browse by category
Search
SURMOUNT-1: Tirzepatide results in 22.5% weight loss in adults with obesity or overweight
Tirzepatide (5 mg, 10 mg, 15 mg) achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli...
Browse by tag
bottom of page